Rigel Pharmaceuticals Inc (RIGL) — Working Capital to Net Assets Ratio

Latest as of June 2026: 21.2%

Rigel Pharmaceuticals Inc (RIGL) has a Working Capital to Net Assets ratio of 21.2% as of June 2026. Working capital of $90.17 Million (current assets of $185.53 Million minus current liabilities of $95.36 Million) is measured against net assets of $425.65 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Rigel Pharmaceuticals Inc liquidity coverage in days to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

21.2%
Working Capital / Net Assets

Working Capital

$90.17 Million
USD

Current Assets

$185.53 Million
USD

Current Liabilities

$95.36 Million
USD

Rigel Pharmaceuticals Inc Working Capital to Net Assets (1999–2025)

This chart shows how Rigel Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 27 annual periods from 1999 to 2025. As of June 2026, the ratio stands at 21.2%, reflecting working capital of $90.17 Million against net assets of $425.65 Million USD. For the complete balance sheet picture, see Rigel Pharmaceuticals Inc (RIGL) total assets.

Annual Working Capital to Net Assets for Rigel Pharmaceuticals Inc (1999–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for Rigel Pharmaceuticals Inc from 1999 to 2025, covering 27 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check RIGL financial resilience to evaluate the company's liquid asset resilience ratio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 36.0% $140.93 Million $391.48 Million $240.17 Million $99.24 Million ▼ -2147.8 pp
2024 2183.8% $71.80 Million $3.29 Million $135.10 Million $63.30 Million ▲ +2344.4 pp
2023 -160.6% $46.00 Million $-28.64 Million $99.27 Million $53.27 Million ▲ +211.7 pp
2022 -372.3% $50.69 Million $-13.62 Million $115.90 Million $65.21 Million ▼ -671.6 pp
2021 299.3% $90.91 Million $30.37 Million $154.47 Million $63.55 Million ▲ +157.8 pp
2020 141.5% $48.14 Million $34.03 Million $88.98 Million $40.84 Million ▲ +28.5 pp
2019 113.0% $60.79 Million $53.81 Million $119.00 Million $58.21 Million ▲ +13.5 pp
2018 99.4% $109.25 Million $109.88 Million $136.99 Million $27.73 Million ▲ +1.0 pp
2017 98.5% $99.10 Million $100.65 Million $117.43 Million $18.34 Million ▲ +1.0 pp
2016 97.5% $53.63 Million $55.03 Million $76.21 Million $22.59 Million ▼ -6.8 pp
2015 104.2% $95.23 Million $91.38 Million $129.02 Million $33.80 Million ▼ -2.2 pp
2014 106.4% $136.51 Million $128.25 Million $150.54 Million $14.03 Million ▲ +5.7 pp
2013 100.7% $209.78 Million $208.25 Million $220.07 Million $10.29 Million ▲ +0.3 pp
2012 100.4% $290.25 Million $289.10 Million $302.46 Million $12.20 Million ▼ -0.7 pp
2011 101.1% $238.71 Million $236.15 Million $250.23 Million $11.53 Million ▼ -0.4 pp
2010 101.5% $168.60 Million $166.13 Million $179.93 Million $11.33 Million ▼ -6.1 pp
2009 107.6% $118.19 Million $109.87 Million $135.97 Million $17.77 Million ▼ -1.8 pp
2008 109.4% $113.94 Million $104.17 Million $138.09 Million $24.15 Million ▼ -6.2 pp
2007 115.6% $95.02 Million $82.18 Million $111.13 Million $16.11 Million ▲ +4.7 pp
2006 110.9% $96.78 Million $87.23 Million $108.01 Million $11.24 Million ▲ +1.4 pp
2005 109.5% $118.95 Million $108.59 Million $142.60 Million $23.65 Million ▼ -10.6 pp
2004 120.1% $62.82 Million $52.30 Million $74.24 Million $11.42 Million ▲ +14.9 pp
2003 105.2% $42.06 Million $39.97 Million $50.11 Million $8.05 Million ▲ +16.8 pp
2002 88.4% $22.49 Million $25.44 Million $36.86 Million $14.37 Million ▼ -2.7 pp
2001 91.1% $26.37 Million $28.94 Million $36.53 Million $10.16 Million ▼ -4.0 pp
2000 95.1% $46.63 Million $49.01 Million $54.68 Million $8.06 Million ▲ +226.1 pp
1999 -131.0% $-990.00K $756.00K $8.53 Million $9.52 Million
pp = percentage points